Metrics as of 10/15/2026, 03:31 PM (Berlin time), refresh in progress.
Jyong Biotech Stock
Jyong Biotech Ltd. Ordinary Shares
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Taiwan
- CEO
- Fu-Feng Kuo
- Employees
- 27
- Market cap
- $156 M
- IPO
- 17/06/2025
Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, and market introduction of botanical therapeutics, specifically aimed at addressing diseases of the urinary system. Its operations are orchestrated through various subsidiary entities, including Health Ever Bio-Tech and…
Jyong Biotech stock: price history
1D
-1.0%
1W
-3.3%
1M
-4.2%
6M
-21.6%
YTD
-48.6%
1Y
-96.5%
2Y
–
5Y
–
10Y
–
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Jyong Biotech
Jyong Biotech stock metrics
P/E
-23.68
P/B
-6.1
EV/EBITDA
-65.89
RETURN ON EQUITY
13.7%
NET MARGIN
0.0%
DEBT/EQUITY
-0.74
DIVIDEND YIELD
0.0%
AS OF
31/12/2025
Free float & liquidity
FREE FLOAT
36.9%
FLOAT SHARES
28,057,727
AVG. DAILY VOLUME (30D)
43,309
Institutional holders
Comparable stocks
Frequently asked questions about Jyong Biotech stock
What does Jyong Biotech do?
Jyong Biotech Ltd. Ordinary Shares is a company in the Healthcare sector, Biotechnology industry, headquartered in Taiwan.
The CEO is Fu-Feng Kuo, the company employs around 27 people.
The IPO was on 17/06/2025; the stock trades on NASDAQ under the ticker MENS.
Does Jyong Biotech pay a dividend?
No, Jyong Biotech currently does not pay a dividend.
Which stocks are comparable to Jyong Biotech?
Comparable stocks include YD Bio, Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines and Incyte.
How can I get Jyong Biotech stock analyzed?
Clicking "Analyze stock" lets five strategies assess Jyong Biotech against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.